LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Technology Businesses for Sale
Wholesale & Distribution Businesses for Sale
Warehouse & Storage Businesses for Sale
Liquor Store Businesses for Sale
Healthcare & Medical Businesses for Sale
Coin Laundry & Dry Cleaning Businesses for Sale
Farms & Vineyards for Sale
Real Estate & Property Management Companies for Sale
Consulting & Training Businesses for Sale
Gas Stations & Car Washes for Sale
Construction & Landscaping Franchise Opportunities
Travel Franchise Opportunities
Warehouse & Storage Franchise for Sale
Employment & Personnel Franchise Opportunities
Pet Franchise Opportunities
Service Franchises for Sale
Gift & Flower Shop Franchise Opportunities
Manufacturing Franchises for Sale
Laundromat & Dry Cleaning Franchise Opportunities
Vending & Kiosk Franchises for Sale
Apartment Buildings for Sale
Commercial Buildings for Sale or Lease
Places of Worship for Sale
Mixed Use Buildings for Sale or Rent
Plazas for Sale
Miscellaneous Properties for Sale or Lease
Industrial Units for Sale or Rent
Medical Buildings for Sale or Lease
Commercial Spaces for Sale or Lease
Retail Buildings for Sale or Lease
An email will be sent to registered email address.
Please select if you are: